CoChat

Trends in the Prevalence of Methylchloroisothiazolinone/Methylisothiazolinone Contact Allergy in North America and Europe

Open access
Reeder, Margo J., Warshaw, Erin, Aravamuthan, Srikanth, Belsito, Donald V., Geier, Johannes, Wilkinson, Mark, Atwater, Amber Reck, White, Ian R., Silverberg, Jonathan I., Taylor, James S., Fowler, Joseph F., Maibach, Howard I., DeKoven, Joel G., Buhl, Timo, Botto, Nina, Giménez-Arnau, Ana Maria, Gallo, Rosella, Mowad, Christen, Lang, Claudia C. V., DeLeo, Vincent A., Johnston, Graham, Pratt, Melanie D., Brockow, Knut, Adler, Brandon L., Houle, Marie-Claude, Dickel, Heinrich, Schuttelaar, Marie Louise A., Yu, JiaDe, Spiewak, Radoslaw, Dunnick, Cory, Filon, Francesca Larese, Valiukevičienė, Skaidra, Uter, Wolfgang · 2023 · JAMA Dermatology
Cited by 58

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Importance: The common use of isothiazolinones as preservatives is a global cause of allergic contact dermatitis. Differences in allowable concentrations of methylisothiazolinone (MI) exist in Europe, Canada, and the US. Objective: To compare the prevalence of positive patch test reactions to the methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) combination and MI alone in North America and Europe from 2009 to 2018. Design, Setting, and Participants: This retrospective analysis of North American Contact Dermatitis Group, European Surveillance System on Contact Allergies (ESSCA), and the Information Network of Departments of Dermatology (IVDK) databases included data from patients presenting for patch testing at referral patch test clinics in North America and Europe. Exposures: Patch tests to MCI/MI and MI. Main Outcomes and Measures: Prevalence of allergic contact dermatitis to MCI/MI and MI. Results: From 2009 to 2018, participating sites in North America and Europe patch tested a total of 226 161 individuals to MCI/MI and 118 779 to MI. In Europe, positivity to MCI/MI peaked during 2013 and 2014 at 7.6% (ESSCA) and 5.4% (IVDK) before decreasing to 4.4% (ESSCA) and 3.2% (IVDK) during 2017 and 2018. Positive reactions to MI were 5.5% (ESSCA) and 3.4% (IVDK) during 2017 and 2018. In North America, the frequency of positivity to MCI/MI increased steadily through the study period, reaching 10.8% for MCI/MI during 2017 and 2018. Positive reactions to MI were 15.0% during 2017 and 2018. Conclusions and Relevance: The study results suggest that in contrast to the continued increase in North America, isothiazolinone allergy is decreasing in Europe. This trend may coincide with earlier and more stringent government regulation of MI in Europe.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamadermatol.2022.5991

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 39

  1. Uter, 2012, Methylchloroisothiazolinone/methylisothiazolinone contact sensitization: diverging trends in subgroups of IVDK patients in a period of 19 years., Contact Dermatitis, 67, 125, 10.1111/cod.2012.67.issue-3 · doi:10.1111/cod.2012.67.issue-3
  2. Fransway, 2013, North American Contact Dermatitis Group patch test results for 2007-2008., Dermatitis, 24, 10, 10.1097/DER.0b013e318277ca50 · doi:10.1097/der.0b013e318277ca50
  3. Dillarstone, 1997, Cosmetic preservatives., Contact Dermatitis, 37, 190, 10.1111/j.1600-0536.1997.tb00205.x · DOI
  4. Castanedo-Tardana, 2013, Methylisothiazolinone., Dermatitis, 24, 2, 10.1097/DER.0b013e31827edc73 · DOI · Paper page
  5. Roberts, 2013, Methylisothiazolinone is categorised as a strong sensitiser in the Murine Local Lymph Node Assay., Contact Dermatitis, 69, 261, 10.1111/cod.12167 · DOI
  6. Fransway, 2019, Parabens., Dermatitis, 30, 3, 10.1097/DER.0000000000000429 · DOI · Paper page
  7. Aerts, 2014, The dramatic increase in the rate of methylisothiazolinone contact allergy in Belgium: a multicentre study., Contact Dermatitis, 71, 41, 10.1111/cod.12249 · DOI · Paper page
  8. Schwensen, 2017, The epidemic of methylisothiazolinone: a European prospective study., Contact Dermatitis, 76, 272, 10.1111/cod.12733 · DOI · Paper page
  9. Isaksson, 2017, Multicenter patch testing with methylisothiazolinone and methylchloroisothiazolinone/methylisothiazolinone within the International Contact Dermatitis Research Group., Dermatitis, 28, 210, 10.1097/DER.0000000000000272 · DOI
  10. Flury, 2018, The methylisothiazolinone contact allergy epidemic in Australia., Contact Dermatitis, 79, 189, 10.1111/cod.2018.79.issue-3 · doi:10.1111/cod.2018.79.issue-3
  11. Ljubojevic Hadžavdic, 2018, Methylisothiazolinone contact allergy in Croatia: epidemiology and course of disease following patch testing., Contact Dermatitis, 79, 162, 10.1111/cod.2018.79.issue-3 · doi:10.1111/cod.2018.79.issue-3
  12. Sukakul, 2021, Methylchloroisothiazolinone and/or methylisothiazolinone contact allergies in Thailand., Dermatitis, 32, 375, 10.1097/DER.0000000000000537 · doi:10.1097/der.0000000000000537
  13. Schnuch, 2020, The methylisothiazolinone epidemic goes along with changing patients’ characteristics—after cosmetics, industrial applications are the focus., Contact Dermatitis, 82, 87, 10.1111/cod.v82.2 · doi:10.1111/cod.v82.2
  14. Uter, 2020, Trends and current spectrum of contact allergy in Central Europe: results of the Information Network of Departments of Dermatology (IVDK) 2007-2018., Br J Dermatol, 183, 857, 10.1111/bjd.v183.5 · doi:10.1111/bjd.v183.5
  15. Urwin, 2017, Methylisothiazolinone: the epidemic is declining—but not gone., Contact Dermatitis, 76, 301, 10.1111/cod.12750 · DOI · Paper page
  16. Havmose, 2021, The epidemic of contact allergy to methylisothiazolinone—an analysis of Danish consecutive patients patch tested between 2005 and 2019., Contact Dermatitis, 84, 254, 10.1111/cod.v84.4 · doi:10.1111/cod.v84.4
  17. DeKoven, 2018, North American Contact Dermatitis Group patch test results: 2015-2016., Dermatitis, 29, 297, 10.1097/DER.0000000000000417 · DOI · Paper page
  18. DeKoven, 2021, North American Contact Dermatitis Group patch test results: 2017-2018., Dermatitis, 32, 111, 10.1097/DER.0000000000000729 · DOI
  19. DeKoven, 2017, North American Contact Dermatitis Group patch test results 2013-2014., Dermatitis, 28, 33, 10.1097/DER.0000000000000225 · DOI · Paper page
  20. Schnuch, 2012, Surveillance of contact allergies: methods and results of the Information Network of Departments of Dermatology (IVDK)., Allergy, 67, 847, 10.1111/all.2012.67.issue-7 · doi:10.1111/all.2012.67.issue-7
  21. Uter, 2016, Registries in clinical epidemiology: the European Surveillance System on Contact Allergies (ESSCA)., Methods Inf Med, 55, 193, 10.3414/ME15-01-0099 · DOI
  22. Uter, 2021, Patch test results with the European baseline series and additions thereof in the ESSCA network, 2015-2018., Contact Dermatitis, 84, 109, 10.1111/cod.v84.2 · doi:10.1111/cod.v84.2
  23. Johansen, 2015, European Society of Contact Dermatitis guideline for diagnostic patch testing—recommendations on best practice., Contact Dermatitis, 73, 195, 10.1111/cod.2015.73.issue-4 · doi:10.1111/cod.2015.73.issue-4
  24. Uter, 2004, Guidelines for the descriptive presentation and statistical analysis of contact allergy data., Contact Dermatitis, 51, 47, 10.1111/cod.2004.51.issue-2 · doi:10.1111/cod.2004.51.issue-2
  25. Burnett, 2019, Amended safety assessment of methylisothiazolinone as used in cosmetics., Int J Toxicol, 38, 70S, 10.1177/1091581819838792 · DOI
  26. Fasth, 2018, Ten-year trends in contact allergy to formaldehyde and formaldehyde-releasers., Contact Dermatitis, 79, 263, 10.1111/cod.2018.79.issue-5 · doi:10.1111/cod.2018.79.issue-5
  27. Garcia-Hidalgo, 2017, Use-patterns of personal care and household cleaning products in Switzerland., Food Chem Toxicol, 99, 24, 10.1016/j.fct.2016.10.030 · DOI
  28. Ficheux, 2015, Consumption of cosmetic products by the French population. first part: frequency data., Food Chem Toxicol, 78, 159, 10.1016/j.fct.2015.01.016 · DOI
  29. Dornic, 2017, Consumption of cosmetic products by the French population. third part: Product exposure amount., Food Chem Toxicol, 106, 209, 10.1016/j.fct.2017.05.049 · doi:10.1016/j.fct.2017.05.049
  30. Biesterbos, 2013, Usage patterns of personal care products: important factors for exposure assessment., Food Chem Toxicol, 55, 8, 10.1016/j.fct.2012.11.014 · DOI · Paper page
  31. Zirwas, 2017, Epidemic of isothiazolinone allergy in North America: prevalence data from the North American Contact Dermatitis Group, 2013-2014., Dermatitis, 28, 204, 10.1097/DER.0000000000000288 · DOI
  32. Schliemann, 2016, Allergic contact dermatitis caused by methylchloroisothiazolinone/methylisothiazolinone in a medical device., Contact Dermatitis, 75, 312, 10.1111/cod.12610 · doi:10.1111/cod.12610
  33. Aerts, 2017, Contact allergy caused by isothiazolinone derivatives: an overview of non-cosmetic and unusual cosmetic sources., Eur J Dermatol, 27, 115, 10.1684/ejd.2016.2951 · DOI · Paper page
  34. Goodier, 2019, Isothiazolinone content of US consumer adhesives: ultrahigh-performance liquid chromatographic mass spectrometry analysis., Dermatitis, 30, 129, 10.1097/DER.0000000000000455 · doi:10.1097/der.0000000000000455
  35. Vauhkala, 2015, Occupational contact allergy to methylchloroisothiazolinone/methylisothiazolinone and methylisothiazolinone., Contact Dermatitis, 73, 150, 10.1111/cod.2015.73.issue-3 · doi:10.1111/cod.2015.73.issue-3
  36. Urwin, 2015, Methylchloroisothiazolinone and methylisothiazolinone contact allergy: an occupational perspective., Contact Dermatitis, 72, 381, 10.1111/cod.2015.72.issue-6 · doi:10.1111/cod.2015.72.issue-6
  37. Hollins, 2020, Occupationally induced allergic contact dermatitis to methylchloroisothiazolinone/methylisothiazolinone among water bottle plant workers., Dermatitis, 31, 265, 10.1097/DER.0000000000000527 · doi:10.1097/der.0000000000000527
  38. DeKoven, 2022, Occupational contact dermatitis: retrospective analysis of North American Contact Dermatitis Group Data, 2001 to 2016., J Am Acad Dermatol, 86, 782, 10.1016/j.jaad.2021.03.042 · DOI
  39. Do, 2021, Multiyear group and medical center patch test frequency data: confounding variables., Dermatitis, 32, 283, 10.1097/DER.0000000000000756 · DOI

Cited by

See all 58

Metadata

Authors
Reeder, M. J., Warshaw, E., Aravamuthan, S., Belsito, D. V., Geier, J., Wilkinson, M., Atwater, A. R., White, I. R., Silverberg, J. I., Taylor, J. S., Fowler, J. F., Maibach, H. I., DeKoven, J. G., Buhl, T., Botto, N., Giménez-Arnau, A. M., Gallo, R., Mowad, C., Lang, C. C. V., DeLeo, V. A., Johnston, G., Pratt, M. D., Brockow, K., Adler, B. L., Houle, M.-C., Dickel, H., Schuttelaar, M. L. A., Yu, J., Spiewak, R., Dunnick, C., Filon, F. L., Valiukevičienė, S., & Uter, W.
Venue
JAMA Dermatology
Published
2023-03-01
Volume
159
Issue
3
Pages
267
ISSN
2168-6068 (ISSN-L)
OpenAlex
W4317234381
Cited by
58
References
2
FWCI
13.18
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.